evolcSign inStart free
Menu

Immunocore

Biotech developing ImmTAX-based T cell receptor therapies for cancer, infectious and autoimmune diseases

Abingdon, United KingdomFounded 2007immunocore.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-28

About Immunocore

Immunocore is a commercial-stage biotechnology company that discovered, developed and commercialized the world's first approved T cell receptor (TCR) therapy, KIMMTRAK (tebentafusp). Its proprietary ImmTAX platform is designed to activate or suppress the immune system through modular bispecific TCR molecules (ImmTAC, ImmTAV, ImmTAAI).

The company develops and sells medicines for patients with cancer, infectious diseases and autoimmune diseases. Its pipeline spans multiple bispecific TCR therapies across solid tumours, HIV, HBV and type 1 diabetes, and it has partnered with companies and foundations including Genentech, GSK and the Bill & Melinda Gates Foundation.

Immunocore Holdings plc is listed as IMCR. The company is headquartered in Abingdon, UK, with its UK R&D and manufacturing base at Milton Park and a site in Gaithersburg, US. Its registered UK entity dates from 2007.

Product: KIMMTRAK (tebentafusp) and a pipeline of bispecific TCR therapies built on the ImmTAX platform

Jobs at Immunocore

No open positions listed right now.

Leadership

  • Bahija Jallal · Chief Executive Officer
    Source: company website
  • Kripa Ram · EVP, Chief Operating Officer
    Source: company website
  • Mohammed Dar · EVP, Clinical Development and Chief Medical Officer
    Source: company website
  • Sean Buckley · VP, Chief Information Officer
    Source: company website
  • Travis Coy · EVP, Chief Financial Officer and Head of Corporate Development
    Source: company website

More biotech & pharma companies

  • Immunokey

    Develops CAR T-cell therapies for solid cancers, starting with ovarian cancer
    Wilmslow, United KingdomBiotech & pharmaFounded 2024
    Young companyNew on Evolc

  • immunologicaltoolbox.co.uk

    Online antibody repository for veterinary immunology researchers, with community ratings and reagent requests
    United KingdomBiotech & pharma
    New on Evolc

  • Immutrin

    Develops antibody therapies to remove amyloid deposits for people with amyloidosis, including ATTR cardiomyopathy
    Cambridge, United KingdomBiotech & pharmaFounded 2019
    New on Evolc

  • IMU Biosciences

    Immune profiling and precision-medicine tools for clinical research, pharmaceutical, biotech and diagnostics organizations
    United KingdomBiotech & pharma1 open job
    Remote-friendly

  • Infectopharm

    Pharmaceutical products for healthcare providers and distribution partners in the UK market
    Marlow, United KingdomBiotech & pharmaFounded 2024
    Young companyNew on Evolc

  • Infinitopes

    Develops off-the-shelf precision cancer vaccines for cancer patients, using tumour-specific targets and engineered viral vectors
    Oxford, United KingdomBiotech & pharmaFounded 2021
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • AWS
  • Apache
  • Google Analytics 4
  • LinkedIn Insight
  • OneTrust